Skip to main content
. 2016 Jun 15;7(34):55840–55862. doi: 10.18632/oncotarget.10095

Figure 5. Cross-regulation between excitatory glutamate NMDAR signaling and the endocannabinoid system: Implications in psychosis and schizophrenia.

Figure 5

A. The activity of NMDARs demands endocannabinoid control via CB1Rs. B. Disproportionate endocannabinoid control could cause NMDAR hypofunction.